Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Result of Extraordinary General Meeting

18th Oct 2011 14:11

RNS Number : 3931Q
3D Diagnostic Imaging PLC
18 October 2011
 



For immediate release

18 October 2011

 

 

3D DIAGNOSTIC IMAGING PLC

("3D" or the "Company")

 

Result of Extraordinary General Meeting

 

3D Diagnostic Imaging (AIM:3DD), which owns the protected rights to a technology platform with a number of significant potential commercial applications, is pleased to announce that all resolutions proposed at its extraordinary general meeting held earlier today were duly passed, and consequently, that the equity fundraising of £1.41m as announced on 22 September 2011 has been completed, subject to admission to trading of the Placing and Subscription Shares.

 

Following the approval by shareholders of the resolution allowing the transfer of management and control of the Company from the Isle of Man to the United Kingdom, Christina Rawlinson and Pritesh Desai have today stepped down from the Board of Directors. The Board would like to thank them for their past contributions to the Company.

 

Application has been made for the admission to trading on AIM of the 13,350,000 First Placing Shares, expected to occur on 19 October 2011, and of the total 57,150,000 Second Placing Shares and Subscription Shares, expected to occur on 20 October 2011. Terms defined in the announcement in respect of the fundraising by the Company dated 22 September 2011 have the same meaning in this announcement unless otherwise stated.

 

Subsequent to the issue of the aggregate 70,500,000 New Ordinary Shares (being, together, the First Placing Shares, the Second Placing Shares and the Subscription Shares), the Company will have 240,974,824 ordinary shares of 0.1p each in issue, with each share carrying the right to one vote. There are no shares held in treasury. The total number of voting rights in the Company will therefore be 240,974,824.

 

The above figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

 

Ends

 

ENDS

 

For further information please contact:

 

3D Diagnostic Imaging Plc

Graham Lay, CEO

+44 (0) 1624 679 000

Oliver Cooke, CFO

+44 (0) 1624 679 000

finnCap: NOMAD & Broker

Geoff Nash, Henrik Persson (corporate finance)

Stephen Norcross (corporate broking)

+44 (0) 2076 001 658

Buchanan Scotland

Diane Stewart, Carrie Clement

+44 (0) 131 226 6150

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGEADEPFEPFFFF

Related Shares:

Afriag Global
FTSE 100 Latest
Value8,275.66
Change0.00